These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 8633095)
21. An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy. Lisziewicz J; Sun D; Trapnell B; Thomson M; Chang HK; Ensoli B; Peng B J Virol; 1995 Jan; 69(1):206-12. PubMed ID: 7983711 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokines. Lisziewicz J; Sun D; Gallo RC; Ensoli B; Lori F Hum Gene Ther; 1996 Dec; 7(18):2209-16. PubMed ID: 8953311 [TBL] [Abstract][Full Text] [Related]
23. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components. Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443 [TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). Shibata R; Miura T; Hayami M; Ogawa K; Sakai H; Kiyomasu T; Ishimoto A; Adachi A J Virol; 1990 Feb; 64(2):742-7. PubMed ID: 2296082 [TBL] [Abstract][Full Text] [Related]
25. A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1. Matsuda Z; Yu X; Yu QC; Lee TH; Essex M Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3544-8. PubMed ID: 7682710 [TBL] [Abstract][Full Text] [Related]
26. A replication-deficient human immunodeficiency virus-1 genome as an interference-inducing provirus. Federico M; Nappi F; Mavilio F; Verani P Antibiot Chemother (1971); 1996; 48():217-25. PubMed ID: 8726528 [No Abstract] [Full Text] [Related]
28. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA. Mautino MR; Morgan RA Hum Gene Ther; 2002 Jun; 13(9):1027-37. PubMed ID: 12067436 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies. Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371 [TBL] [Abstract][Full Text] [Related]
30. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication. Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403 [TBL] [Abstract][Full Text] [Related]
31. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication. Popik W; Pitha PM Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses. Inoue M; Hoxie JA; Reddy MV; Srinivasan A; Reddy EP Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2278-82. PubMed ID: 2006168 [TBL] [Abstract][Full Text] [Related]
33. Biological importance and cooperativity of HIV-1 regulatory gene splice acceptors. Riggs NL; Little SJ; Richman DD; Guatelli JC Virology; 1994 Jul; 202(1):264-71. PubMed ID: 8009838 [TBL] [Abstract][Full Text] [Related]
34. Structure of simian immunodeficiency virus regulatory genes. Colombini S; Arya SK; Reitz MS; Jagodzinski L; Beaver B; Wong-Staal F Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4813-7. PubMed ID: 2544874 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes. VandenDriessche T; Chuah MK; Chiang L; Chang HK; Ensoli B; Morgan RA J Virol; 1995 Jul; 69(7):4045-52. PubMed ID: 7769662 [TBL] [Abstract][Full Text] [Related]
36. Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Tiley LS; Brown PH; Le SY; Maizel JV; Clements JE; Cullen BR Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7497-501. PubMed ID: 2170981 [TBL] [Abstract][Full Text] [Related]
37. A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus. Federico M; Nappi F; Ferrari G; Chelucci C; Mavilio F; Verani P J Virol; 1995 Nov; 69(11):6618-26. PubMed ID: 7474070 [TBL] [Abstract][Full Text] [Related]
38. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections. Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799 [TBL] [Abstract][Full Text] [Related]
39. Comparative studies on tat mutants of three primate lentiviruses. Shibata R; Sakai H; Ogawa K; Ishimoto A; Adachi A Arch Virol; 1990; 114(3-4):243-50. PubMed ID: 1700693 [TBL] [Abstract][Full Text] [Related]